XBiotech (XBIT) Gains Following Post-IPO Pullback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500 volatile in choppy trading; Mideast deal, SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
XBiotech (XBIT) IPO Opens Up 21%
April 15, 2015 11:17 AM EDTToday's IPO for XBiotech Inc., (Nasdaq: XBIT) opened for trading at $23 after pricing 4,000,000 shares of its common stock at an initial public offering price of $19.00 per share.
WR Hambrecht + Co is acting as the sole underwriter for the offering.
XBiotech is a leading developer... More
